Safety of cytotoxic chemotherapy during pregnancy

Journal of the Pakistan Medical Association

Volumn 57, Issue 9, 2007, Pages 449-452

  Jameel, Abid ^a   Jamil, Shahnaz Nadir ^a  

^a KHYBER MEDICAL UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACARBAZINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; METOCLOPRAMIDE; PREDNISOLONE; RETINOIC ACID; TROPISETRON; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE; CYTOTOXIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; AXILLA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; FEMALE; FETUS DEATH; FETUS MALFORMATION; FOLLOW UP; GESTATIONAL AGE; HODGKIN DISEASE; HUMAN; LIVE BIRTH; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PREGNANCY; RECURRENT CANCER; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SOFT TISSUE SARCOMA; SPONTANEOUS ABORTION; TEACHING HOSPITAL; THERAPEUTIC ABORTION; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; BREAST TUMOR; DRUG TOXICITY; NEOPLASM; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROSPECTIVE STUDY; TIME;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CYTOTOXINS; DRUG TOXICITY; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 38449100263     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kennedy S, Yudkin P, Greenall M. Cancer in pregnancy. Eur J Surg Oncol 1993; 19:405-7.
2. Ward RM, Bristow RE. Cancer and pregnancy: recent developments. Curr Opin Obstet Gynecol 2002; 14:613-17.
3. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary E, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855-61.
4. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004; 15: 146-50.
5. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Human Reproduction Update 2001; 7: 384-93.
6. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: An 18 year experience from five London Teaching Hospitals. J Clin Oncol 2005; 23: 4192-97.
7. Usmani K, Moran EM, Haider W, Afzal H, Ahmad N. Breast cancer in pregnant and lactating women. J Environ Pathol Toxicol Oncol 1995; 14: 227-34.
8. Aziz S, Pervez S, Khan S, Siddiqui T, Kayani N, Israr M, et al. Case control study of novel prognostic markers and disease outcome in pregnancy-lactation-associated breast cancer. Pathol Res Pract 2003; 199: 15-21.
9. Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol 2005; 105: 1098-1103.
10. Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002; 194: 54-64.
11. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast cancer during pregnancy: A French national survey. Cancer 1999; 86: 2266-72.
12. Van Calsteren K, Vergote I, Amant F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gyneacol 2005; 19: 611-30.
13. Caluwaerts S, Van Calsteren K, Mertens L, Lagae L, Moerman P, Hanssens M, et al. Neo-adjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of literature. Int J Gynecol Cancer 2006; 16: 905-08.
14. Yucesoy G, Buyukgebiz O, Yildiz K, Cakiroglu Y, Ozkan S, Bodur H. Gastric carcinoma diagnosed at the third trimester: a case report. Arch Gynecol Obstet 2006; 274: 47-49.
15. Ault P, Kantarjian H, O'Brien S, Faderl S, Beran M, Rios M, et al. Pregnancy among patients with chronic myeloid leukemia treated with Imatinib. J Clin Oncol 2006; 24: 1204-08.
16. Prabhash K, Sastry PS, Biswas G, Bakshi A, Prasad N, Menon H, et al. Pregnancy outcome of two patients treated with Imatinib. Ann Oncol 2005; 16: 1983-84.
17. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto Leukemia study Group experience with long term follow-up of children exposed in-utero to chemotherapeutic agents. J Clin Oncol 1987; 5: 1098-1106.
18. Chelghoum Y, Vey N, Raffoux E, Huguet F, Pigneux A, Witz B, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of literature. Cancer 2005; 104: 110-17.
19. De Carolis S, Grimolizzi F, Garofalo S, Fatigante G, Ferrazzani S, Carducci B, et al. Cancer in pregnancy: results of a series of 32 patients. Anticancer Res 2006; 26: 2413-18.
20. Niedermeier DM, Frei-Lahr DA, Hall PD. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 2005; 25: 1134-40.
21. Nugent P, O'Conell TX. Breast cancer and pregnancy. Arch Surg 1985; 120: 1221-24.
22. Moor HC, Foster RS Jr. Breast cancer and pregnancy. Semin Oncol 2000; 27: 646-53.
23. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 1992; 65: 114-17.
24. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001; 2: 173-77.
25. Van Calsteren K, Berteloot P, Hanssens M, Vergote I, Amant F, Ganame J et al. In-utero exposure to chemotherapy: Effect on cardiac and neurologic outcome. J Clin Oncol 2006; 24: 16-17.